Literature DB >> 3829173

Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues.

E Murayama, K Miyamoto, N Kubodera, T Mori, I Matsunaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3829173     DOI： 10.1248/cpb.34.4410

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  8 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog.

Authors:  K Takeyama; Y Masuhiro; H Fuse; H Endoh; A Murayama; S Kitanaka; M Suzawa; J Yanagisawa; S Kato
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.

Authors:  A J Brown; C R Ritter; J L Finch; J Morrissey; K J Martin; E Murayama; Y Nishii; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

Review 4.  The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Authors:  Ladan Zand; Rajiv Kumar
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

5.  Vitamin D: The "sunshine" vitamin.

Authors:  Rathish Nair; Arun Maseeh
Journal:  J Pharmacol Pharmacother       Date:  2012-04

6.  Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines.

Authors:  S Kawa; T Nikaido; Y Aoki; Y Zhai; T Kumagai; K Furihata; S Fujii; K Kiyosawa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.

Authors:  Yoshihisa Hirota; Kimie Nakagawa; Keigo Isomoto; Toshiyuki Sakaki; Noboru Kubodera; Maya Kamao; Naomi Osakabe; Yoshitomo Suhara; Toshio Okano
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

8.  Calcitriol and cancer therapy: A missed opportunity.

Authors:  Donald L Trump
Journal:  Bone Rep       Date:  2018-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.